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1. Introduction 2. Materials and methods 
Catecholamine stimulation of hepatic gluconeo- 
genesis [1-3] and glycogenolysis [3] in the rat is 
mediated by c¢-adrenergic receptors without the par- 
ticipation of cAMP. An involvement of Ca 2+ in 
response to activation of the ~-adrenergic receptor is 
widely recognized [4]. Catecholamines could elicit a 
rise in cytosolic [Ca 2+] [5-8]. 
Ca 2+ must be present in the suspending medium to 
enable catecholamines to enhance gluconeogenesis 
from reduced substrates that enter the pathway at 
triose phosphate (i.e., glycerol or sorbitol) [9,10]. 
This is not the case for their oxidized counterparts, 
dihydroxyacetone or fructose, from which gluconeo- 
genesis can be stimulated by catecholamines ven in 
the absence of medium Ca 2+. With the reduced sub- 
strates in the presence of medium Ca 2+, catechol- 
amines caused the oxidation of cytosolic NADH and 
the reduction of mitochondrial NAD [10]. Further- 
more, it was noted that aminooxyacetate, a trans- 
aminase inhibitor that blocks the malate-aspartate 
shuttle, cannot prevent catecholamine stimulation of 
gluconeogenesis from the reduced triose substrates. 
We therefore suggested the involvement of the glycero- 
phosphate shuttle in removing excess reducing equiva- 
lents when catecholamines are present [9]. 
Here, the transfer of reducing equivalents (NADH) 
from the cytosol to the mitochondria was studied by 
examining ethanol oxidation by fasted hepatocytes. 
The results provide further evidence for the participa- 
tion of the glycerophosphate shuttle in catecholamine 
action. 
2.1. Preparation and incubation of  hepatocytes 
The preparation was essentially that in [ 11 ] 
except hat immediately upon cannulation of the 
liver, Ca2+-free Krebs-Henseleit buffer [12] was 
passed through the liver and flow continued until the 
liver was excised. After connecting the liver to the 
perfusion apparatus, a further 50 ml Krebs-Henseleit 
buffer (at 37°C) was flushed through; then 50 mg col- 
lagenase was added to the remaining 100 ml perfusion 
fluid. Viability of hepatocytes u ed was 85-95% (as 
judged by trypan blue exclusion). 
Cells were incubated in rubber-stoppered 25 ml 
flasks in a total volume of 2 ml, containing Krebs- 
Henseleit medium, 2.5% bovine serum albumin (char- 
coal treated as in [13] and dialyzed) and 2.4 mM 
CaC12, or no added Ca 2+ where indicated. Dry weights 
were determined by weighing dried aliquots of the 
hepatocyte suspension and the values converted to 
wet weights by multiplying by the conversion factor 
3.7 [14]. 
2.2. Measurement of ethanol oxidation 
Ethanol oxidation by hepatocytes was determined 
as in [ 15]. Ethanol was initially 2.5 mM; and ethanol 
oxidation was linear with time for up to 40 min, 
depending on cell concentration and additions to the 
medium. The incubations were terminated after 
30 min by the addition of perchloric acid (final conc. 
1.5%). Shorter incubation periods (15 min) were used 
when pyruvate or lactate were added, but the results 
were independent of cell concentration over a range 
of 30-60 mg wet wt hepatocytes. Controls incubated 
without hepatocytes or with cells plus perchlorate 
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Table 1 
Catecholamine stimulation ofethanol oxidation by isolated 
rat hepatocytes 
Addition 
(mM) 
Rate of ethanol oxidation 
Control + 10/~M 
Epinephrine 
None 0.76 _+ 0.03 1.02 ± 0.04 b 
AOA a (0.05) 0.45 ± 0.01 0.61 ± 0.03 b 
Lactate (10) 1.58 ± 0.14 1.81 ± 0.17 b 
Lactate + AOA 0.62 -+ 0.02 0.87 ± 0.05 b 
Pyruvate (10) 2.77 +_ 0.15 2.74 _+ 0.16 
Medium Ca ~÷ dmitted 0.50 +- 0.03 0.51 ± 0.04 
Propranolol (0.1) 0.74 ± 0.04 0.97 ± 0.07 b 
Prazosin (5 X 10 -4) 0.76 ± 0.04 0.76 ± 0.05 
Phenylephrine (0.05) 1.08 ± 0.04 c 
Angiotensin (0.01) 1.05 ± 0.11 c 
Angiotensin +prazosin 1.04 ± 0.09 c 
A23187 (0.01) 1.08 ± 0.08 c 
a AOA, aminooxyacetate 
b p < 0.05 vs corresponding control without epinephrine 
c p < 0.05 vs control with no addition 
Rates of ethanol oxidation are in gmol. rain -1 . g wet wt -1 
and expressed as mean ± SEM. Results of 4 separate prepara- 
tions are presented. For details of the incubation procedure 
see section 2 
from the beginning of-the incubation displayed no 
loss of ethanol. 
2.3. Animals and chemicals 
Male Sprague-Dawley rats (200-300 g), fasted 
48 h prior to hepatocyte isolation, were used through- 
out. Collagenase (CSL II) was from Worthington, 
propranolol from Ayerst, aminooxyacetate from 
Upjohn, and prazosin was a gift from Pfizer. All other 
chemicals were from Sigma. 
3. Results 
The rate of ethanol oxidation by hepatocytes from 
fasted rats is a reflection of shuttle activities transfer- 
ring reducing equivalents from NADH in the cytosol 
to the mitochondrial matrix [ 16]. Table 1 shows that 
ethanol oxidation was stimulated by epinephrine and 
that this stimulation persisted when the malate-  
aspartate shuttle was blocked by aminooxyacetate or 
accelerated by the addition of lactate. Addition of 
lactate plus aminooxyacetate resulted in an inter- 
mediate rate of ethanol oxidation* which was also 
stimulated by epinephrine. In the presence of pyr- 
uvate, which directly reoxidizes cytosolic NADH, 
ethanol oxidation is shuttle-independent andwas 
accordingly unaffected by epinephrine. Table 1 also 
demonstrates that epinephrine was ineffective in the 
absence of medium Ca 2÷. 
The adrenergic specificity of the catecholamine 
response was demonstrated by showing that the al- 
antagonist prazosin [17] blocked the stimulation of 
ethanol oxidation but propanolol did not. Furthermore, 
both phenylephrine (an a-agonist) and angiotensin, 
which causes an increased cytosolic Ca 2+ [7], mim- 
icked the epinephrine r sponse. Angiotensin was still 
effective in the presence of prazosin, eliminating non- 
specific inhibition by the a-antagonist. Finally the 
Ca 2+ ionophore, A23187, also caused an augmented 
rate of ethanol oxidation. 
4. Discussion 
The results of catecholamine stimulation of etha- 
nol oxidation parallel our previous findings with 
reduced substrates for gluconeogenesis. Catechol- 
amines timulated both ethanol oxidation and gluco- 
neogenesis from reduced substrates that enter the 
gluconeogenesis pathway at the level of triose phos- 
phate [9] even in the presence of the malate-aspar- 
tare shuttle inhibitor, aminooxyacetate. The elimina- 
tion of the epinephrine stimulation with prazosin, but 
not propranolol, and the duplication of the epineph- 
rine response by phenylephrine suggest that in rat 
liver, catecholamines stimulate thanol oxidation 
through c~-receptors just as they stimulate gluconeo- 
genesis. The demonstration that ethanol oxidation 
can be stimulated by epinephrine even in the presence 
of lactate, which augments the intermediates for the 
malate-aspartate shuttle [15], provides further proof 
that the stimulation of reducing equivalent transport 
is localized to the glycerophosphate shuttle. 
The important facet of catecholamine r sponse is
the augmentation f cytosolic Ca 2÷, since angiotensin, 
* In hepatocytes metabolizing ethanol, addition of 10 mM 
lactate causes a>2-fold rise in glutamate concentration 
[ 14]. Glutamate can protect glutamate-oxalacetate tr ns- 
aminase against aminooxyacetate inhibition (N. W. CorneU, 
personal communication). This would explain why the 
transaminase inhibitor does not suppress ethanol oxidation 
as completely in the presence of lactate as in its absence 
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which increases this pool [7], also stimulated ethanol 
oxidation. In [ 18], glucose synthesis from glycerol, 
but not fructose, was stimulated by this hormone. 
Our results uggest the explanation for the results in 
[ 18] is that angiotensin stimulates the glycerophos- 
phate shuttle and removes the excess cytosolic NADH 
generated when glycerol is the substrate for gluconeo- 
genesis. 
That a rise in cytosolic Ca 2÷ is part of the catechol- 
amine stimulation of gluconeogenesis has been often 
suggested. The mitochondrial glycerophosphate 
dehydrogenase, situated on the outer face of the 
inner membrane, has been demonstrated to be stimu- 
lated by Ca 2÷ in several tissues including rat liver [ 19]. 
Beyond removal of excess reducing equivalents, 
there must be an alternative site of catecholamine 
action since gluconeogenesis from both lactate and 
pyruvate is stimulated by catecholarnines. A possible 
mechanism for activation of phosphoenolpyruvate 
carboxykinase has been reported [20]. 
These findings suggest that reducing equivalent 
transfer can now be assessed in the whole cell, mea- 
suring either glycerol gluconeogenesis or ethanol oxi- 
dation as a reflection of the increased cytosolic Ca 2÷ 
triggered by catecholamines. 
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